SMTL ID : 8g8o.1

The crystal structure of JAK2 in complex with Compound 31

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

homo-dimer

Ligands

2 x YT0: [1-{5-methyl-2-[(3-methyl-1,2-thiazol-5-yl)amino]pyrimidin-4-yl}-3-(4-methylpiperazin-1-yl)azetidin-3-yl]acetonitrile(Non-covalent)

YT0.1: 16 residues within 4Å: Chain A: G.42, K.43, G.44, V.49, A.66, M.115, E.116, Y.117, L.118, G.121, R.166, N.167, I.168, L.169, G.179, D.180 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:A.66, A:Y.117, A:L.169 Hydrogen bonds: A:L.118, A:L.118 Water bridges: A:S.122 Salt bridges: A:D.180, A:D.180 YT0.3: 16 residues within 4Å: Chain B: L.41, G.42, G.44, V.49, A.66, M.115, E.116, Y.117, L.118, G.121, R.166, N.167, I.168, L.169, G.179, D.180 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:A.66, B:Y.117, B:L.169 Hydrogen bonds: B:L.118, B:L.118, B:G.179 Water bridges: B:S.122 Salt bridges: B:D.180, B:D.180

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.2: 2 residues within 4Å: Chain A: G.154, V.219 No protein-ligand interaction detected (PLIP)

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.4: 7 residues within 4Å: Chain B: F.205, W.224, V.228, F.247, R.273, L.274, W.292 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:F.205, B:L.274

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gordhan, H.M. et al., Eyes on Topical Ocular Disposition: The Considered Design of a Lead Janus Kinase (JAK) Inhibitor That Utilizes a Unique Azetidin-3-Amino Bridging Scaffold to Attenuate Off-Target Kinase Activity, While Driving Potency and Aqueous Solubility. J.Med.Chem. (2023)

Release Date

2023-06-21

Peptides

Tyrosine-protein kinase JAK2: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence